Renée Gal

2021

In 2021, Renée Gal earned a total compensation of $4.6M as Executive Vice President and CFO at Jazz Pharmaceuticals, a 12% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$400,000
Salary$616,923
Stock Awards$3,577,891
Other$10,410
Total$4,605,224

Gal received $3.6M in stock awards, accounting for 78% of the total pay in 2021.

Gal also received $400K in non-equity incentive plan, $616.9K in salary and $10.4K in other compensation.

Rankings

In 2021, Renée Gal's compensation ranked 2,871st out of 12,406 executives tracked by ExecPay. In other words, Gal earned more than 76.9% of executives.

ClassificationRankingPercentile
All
2,871
out of 12,406
77th
Division
Manufacturing
1,143
out of 5,492
79th
Major group
Chemicals And Allied Products
451
out of 2,368
81st
Industry group
Drugs
395
out of 2,089
81st
Industry
Pharmaceutical Preparations
264
out of 1,536
83rd

Pay ratio

Renée Gal's Pay$4,605,224
Median Employee's Pay$212,134
Pay Ratio

22

to 1

In 2021, the annual total compensation of Renée Gal was $4,605,224.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.

The ratio of Renée Gal's pay to the pay of median employee was therefore 22 to one.

Source: SEC filing on June 10, 2022.

Gal's colleagues

We found four more compensation records of executives who worked with Renée Gal at Jazz Pharmaceuticals in 2021.

2021

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2021

Daniel Swisher

Jazz Pharmaceuticals

President

2021

Chris Tovey

Jazz Pharmaceuticals

Chief Operating Officer

2021

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like